Rational Design of Highly Cytotoxic η6-Arene β-Diketiminato−Ruthenium Complexes

Tunable Anticancer Activity of Furoylthiourea-Based RuII -Arene Complexes and Their Mechanism of Action

Fourteen new Ru^II -arene (p-cymene/benzene) complexes (C1-C14) have been synthesized by varying the N-terminal substituent in the furoylthiourea ligand and satisfactorily characterized by using analytical and spectroscopic techniques. Electrostatic potential maps predicted that the electronic effect of the substituents was mostly localized, with some influence seen on the labile chloride ligands. The structure-activity relationships of the Ru-p-cymene and Ru-benzene complexes showed opposite trends. All the complexes were found to be highly toxic towards IMR-32 cancer cells, with C5 (Ru-p-cymene complex containing C₆ H₂ (CH₃ )₃ as N-terminal substituent) and C13 (Ru-benzene complex containing C₆ H₄ (CF₃ ) as N-terminal substituent) showing the highest activity among each set of complexes, and hence they were chosen for further study. These complexes showed different behavior in aqueous solutions, and were also found to catalytically oxidize glutathione. They also promoted cell death by apoptosis and cell cycle arrest. Furthermore, the complexes showed good binding ability with the receptors Pim-1 kinase and vascular endothelial growth factor receptor 2, commonly overexpressed in cancer cells.

Ligand- and Metal-Based Reactivity of a Neutral Ruthenium Diolefin Diazadiene Complex: The Innocent, the Guilty and the Suspicious

Coordination of the diazadiene diolefin ligand (trop2 dad) to ruthenium leads to various complexes of composition [Ru(trop2 dad)(L)]. DFT studies indicate that the closed-shell singlet (CSS), open-shell singlet (OSS), and triplet electronic structures of this species are close in energy, with the OSS spin configuration being the lowest in energy for all tested functionals. Singlet-state CASSCF calculations revealed a significant multireference character for these complexes. The closed-shell singlet wavefunction dominates, but these complexes have a significant (≈8-16 %) open-shell singlet [d7 -RuI (L)(trop2 dad.- )] contribution mixed into the ground state. In agreement with their ambivalent electronic structure, these complexes reveal both metal- and ligand-centered reactivity. Most notable are the reactions with AdN3 , diazomethane, and a phosphaalkyne leading to scission of the C-C bond of the diazadiene (dad) moiety of the trop2 dad ligand, resulting in net (formal) nitrene, carbene, or P≡C insertion in the dad C-C bond, respectively. Supporting DFT studies revealed that several of the ligand-based reactions proceed via low-barrier radical-type pathways, involving the dad.- ligand radical character of the OSS or triplet species.

Molybdenum(0) Dihapto-Coordination of Benzene and Trifluorotoluene: The Stabilizing and Chemo-Directing Influence of a CF3 Group

The preparation of the complexes TpMo(NO)(DMAP)(η²-PhCF₃) (5) and TpMo(NO)(DMAP)(η²-benzene) (3) is described. The CF₃ group is found to stabilize the metal-arene bond strength in 5 by roughly 3 kcal/mol compared to that in 3, allowing the large-scale synthesis and isolation of the trifluorotoluene analogue (5, 37 g, 70%). When a benzene solution of 5 is allowed to stand, clean conversion to the benzene analogue 3 occurs, and this complex may be precipitated from solution upon the addition of pentane and isolated. The trifluorotoluene complex is shown to be a synthetic precursor to functionalized cyclohexadienes: In solution, it selectively protonates at the ortho position, and the resulting η²-arenium species undergoes reactions with nucleophiles at the adjacent meta carbon. Thus, reactions of 5, triflic acid, and either N-methylpyrrole or 1-methoxy-2-methyl-1-(trimethylsilyloxy)-1-propene result in 5-substituted-1,3-cyclohexadienes after removal of the metal.

Aminophosphine ligands as a privileged platform for development of antitumoral ruthenium(ii) arene complexes

The potential utility of aminophosphine ligands in both high-throughput testing and rational design of new anticancer metallodrugs.

The half-sandwich 18- and 16-electron arene ruthenium iminophosphonamide complexes

Novel arene ruthenium iminophosphonamides are electron-rich complexes due to a strong σ,π-donor zwitterionic ligand.

On the non-innocence of “Nacnacs”: ligand-based reactivity in β-diketiminate supported coordination compounds

While β-diketiminate (BDI or ‘nacnac’) ligands have been widely adopted to stabilize a wide range of metal ions in multiple oxidation states and coordination numbers, in several occurrences these ligands do not behave as spectators and participate in reactivity.

Tuning steric and electronic effects in transition-metal β-diketiminate complexes

β-Diketiminates are widely used supporting ligands for building a range of metal complexes with different oxidation states, structures, and reactivities. This Perspective summarizes the steric and electronic influences of ligand substituents on these complexes, with an eye toward informing the design of new complexes with optimized properties. The backbone and N-aryl substituents can give significant steric effects on structure, reactivity and selectivity of reactions. The electron density on the metal can be tuned by installation of electron withdrawing or donating groups on the β-diketiminate ligand as well. Examples are shown from throughout the transition metal series to demonstrate different types of effects attributable to systematic variation of β-diketiminate ligands.

Catalytic transfer hydrogenation and anticancer activity of arene–ruthenium compounds incorporating bi-dentate precursors

A series of arene–Ru compounds were synthesized and their catalytic transfer hydrogenation and anticancer activity towards human hormone-refractory prostate cancer were investigated.

Iron and chromium complexes containing tridentate chelates based on nacnac and imino- and methyl-pyridine components: triggering C-X bond formation

Nacnac-based tridentate ligands containing a pyridyl-methyl and a 2,6-dialkyl-phenylamine (i.e., (2,6-R2-C6H3N═C(Me)CH═C(Me)NH(CH2py); R = Et, {Et(nn)PM}H; R = (i)Pr, {(i)Pr(nn)PM}H) were synthesized by condensation routes. Treatment of M{N(TMS)2}THFn (M = Cr, n = 2; M = Fe, Co, n = 1; TMS = trimethylsilane; THF = tetrahydrofuran) with {(i)Pr(nn)PM}H) afforded {(i)Pr(nn)PM}MN(TMS)2 (1-M(iPr); M = Cr, Fe); {Et(nn)PM}MN(TMS)2 (1-M(Et); M = Fe, Co) was similarly obtained. {R(nn)PM}FeBr (R = (i)Pr, Et; 2-Fe(R)) were prepared from FeBr2 and {R(nn)PM}Li, and alkylated to generate {R(nn)PM}Fe(neo)Pe (R = (i)Pr, Et; 3-Fe(R)). Carbonylation of 3-Fe(R) provided {(i)Pr(nn)PM}Fe(CO(neo)Pe)CO (4-Fe(iPr)), and carbonylations of 1-Fe(R) (R = Et, (i)Pr) and 1-Cr(iPr) induced deamination to afford {R(nn)PI}Fe(CO)2 (R = (i)Pr, 5-Fe(iPr); Et, 5-Fe(Et)), where PI is pyridine-imine, and {κ(2)-N,N-pyrim-pyr}Cr(CO)4 (6-Cr(iPr)), in which the aryl-amide side of the nacnac attacked the incipient PI group. Carbon-carbon bonds were formed at the imine carbon of the {R(nn)PI} ligand. Addition of [{(i)Pr(nn)PI}(2-)](K(+)(THF)x)2 to FeCl3 generated {(i)Pr(nn)CHpy}2Fe2Cl2 (7-Fe(iPr)), and TMSN3 induced the deamination of 1-Fe(Et), but with disproportionation to provide {[Et(nn)CHpy]2}Fe (8-Fe(Et)). Ph2CN2 induced C-C bond formation with 1-Fe(iPr) via its thermal degradation to ultimately afford {(i)Pr(nn)CHpy}2(FeN═CPh2)2 (9-Fe(iPr)). The compounds were examined by X-ray crystallography (1-M(iPr), M = Cr, Fe; 1-Co(Et); 2-Fe(iPr); 4-Fe(iPr); 5-Fe(iPr); 6-Cr(iPr); 7-Fe(iPr); 8-Fe(Et); 9-Fe(iPr)), Mössbauer spectroscopy, and NMR spectroscopy. Structural parameters assessing redox noninnocence are discussed, as are structural and mechanistic consequences of the various electronic environments.

Iron complexes derived from {nacnac-(CH2py)2}- and {nacnac-(CH2py)(CHpy)}n ligands: stabilization of iron(II) via redox noninnocence

Nacnac-based tetradentate chelates, {nacnac-(CH2py)2}(-) ({nn(PM)2}(-)) and {nacnac-(CH2py)(CHpy)}(n) ({nn(PM)(PI)}(n)) have been investigated in iron complexes. Treatment of Fe{N(TMS)2}2(THF) with {nn(PM)2}H afforded {nn(PM)2}FeN(TMS)2 [1-N(TMS)2], which led to {nn(PM)2}FeCl (1-Cl) from HCl and to {nn(PM)2}FeN3 (1-N3) upon salt metathesis. Dehydroamination of 1-N(TMS)2 was induced by L (L = PMe3, CO) to afford {nn(PM)(PI)}Fe(PMe3)2 [2-(PMe3)2] and {nn(PM)(PI)}FeCO (3-CO). Substitution of 2-(PMe3)2 led to {nn(PM)(PI)}Fe(PMe3)CO [2-(PMe3)CO], and exposure to a vacuum provided {nn(PM)(PI)}Fe(PMe3) (3-PMe3). Metathesis routes to {nn(PM)(PI)}FeL2 (2-L2; L = PMe3, PMe2Ph) and {nn(PM)(PI)}FeL (3-L; L = PMePh2, PPh3) from [{nn(PM)(PI)}(2-)]Li2 and FeBr2(THF)2 in the presence of L proved feasible, and 1e(-) and 2e(-) oxidation of 2-(PMe3)2 afforded 2(+)-(PMe3)2 and 2(2+)-(PMe3)2 salts. Mössbauer spectroscopy, structural studies, and calculational assessments revealed the dominance of iron(II) in both high-spin (1-X) and low-spin (2-L2 and 3-L) environments, and the redox noninnocence (RNI) of {nn(PM)(PI)}(n) [2-L2, 3-L, n = 2-; 2(+)-(PMe3)2, n = 1-; 2(2+)-(PMe3)2, n = 0]. A discussion regarding the utility of RNI in chemical reactivity is proffered.

cis-1,3,5-Triaminocyclohexane as a facially capping ligand for ruthenium(II)

Reaction of cis-[RuCl2(DMSO-S)3(DMSO-O)] with cis-1,3,5-triaminocyclohexane (tach) results in the formation of [RuCl(tach)(DMSO-S)2]Cl, a valuable precursor for a wide range of other tach-containing Ru complexes. Reaction of [RuCl(tach)(DMSO-S)2]Cl with the chelating nitrogen-based ligands (N-N = bipyridine, phenanthroline, and ethylenediamine) affords [Ru(N-N)(DMSO-S)2(tach)][Cl]2. A similar reaction between [RuCl(tach)(DMSO-S)]Cl with the chelating phosphorus-based ligands (P-P = dppm, dppe, dppp, dppb, dppv, and dppben) leads to the formation of [RuCl(P-P)(tach)]Cl. The structures of 10 examples of the tach-containing complexes have been determined by single crystal X-ray diffraction. An examination of the structural metrics obtained from these studies indicates that the tach ligand is a strong sigma donor. In addition, the presence of the NH2 groups in the tach ligand allow for participation in hydrogen bonding further modulating the coordinative properties of the ligand.

Cationic ruthenium(III) maltolato–imidazole complexes — Synthesis, characterization, and antiproliferatory activity*Adapted from the Ph.D. thesis of D.C. Kennedy (see the References section)

The cationic RuIII complexes, trans-[Ru(ma)2(L)2]CF3SO3, where Hma = maltol = 3-hydroxy-2-methyl-4-pyrone; L = imidazole (Im) (complex 2), 1(N)-methylimidazole (N-MeIm) (3), 2-methylimidazole (2-MeIm) (4), and 4-methylimidazole (4-MeIm) (5), were synthesized via the known L = EtOH (complex 1a), and characterized by elemental analysis, 1H NMR and IR spectroscopies, mass spectrometry, cyclic voltammetry, and (for 3 and 4) by X-ray crystallography. The trans-[Ru(ma)2(H2O)2]CF3SO3 complex (1b) was inadvertently isolated and characterized crystallographically, and the monomaltolato species [Ru(ma)(N-MeIm)4][CF3SO3]2 (6) was also isolated and characterized. In vitro antiproliferatory activity of complexes 2−6 against human breast cancer cells (MDA-MB-435S) was tested using an MTT assay: 4 and 5 exhibit the lowest IC50 values, ~5 and ~15 µmol/L, respectively, whereas cisplatin exhibits an IC50 value of ~35 µmol/L against this cell line.